ID
23246
Beskrivning
Responsible Party: Dominik Bettinger, investigator, University Hospital Freiburg ClinicalTrials.gov Identifier: NCT01360255 History of Changes Other Study ID Numbers: HCC2 DRKS00000812 ( Registry Identifier: German Clinical Trials Register ) Study First Received: May 9, 2011 Last Updated: December 14, 2011 AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT01360255
Länk
https://clinicaltrials.gov/ct2/show/NCT01360255
Nyckelord
Versioner (1)
- 2017-06-30 2017-06-30 -
Uppladdad den
30 juni 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatocellular Carcinoma DRKS00000812 NCT01360255 DRKS00000812
Eligibility Hepatocellular Carcinoma NCT01360255 DRKS00000812
- StudyEvent: ODM
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beskrivning
Control Group
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0009932
Beskrivning
Liver tumor of unknown origin
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C2239176
- UMLS CUI [1,2]
- C0346426
Beskrivning
Other liver tumors
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C2239176
Beskrivning
Contraindication to TACE
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C3539919
- UMLS CUI [1,2]
- C1301624
Similar models
Eligibility Hepatocellular Carcinoma NCT01360255 DRKS00000812
- StudyEvent: ODM
C1301732 (UMLS CUI [1,2])
C0346426 (UMLS CUI [1,2])
C2239176 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,2])